Aprea Therapeutics, Inc. (APRE)
0.7740
-0.02
(-1.93%)
USD |
NASDAQ |
Sep 11, 16:00
0.7899
+0.02
(+2.06%)
After-Hours: 20:00
Aprea Therapeutics Market Cap : 9.590M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 9.590M |
| September 10, 2026 | 9.779M |
| September 09, 2026 | 9.806M |
| September 08, 2026 | 10.35M |
| September 04, 2026 | 9.842M |
| September 03, 2026 | 9.991M |
| September 02, 2026 | 10.16M |
| September 01, 2026 | 10.36M |
| August 31, 2026 | 9.913M |
| August 28, 2026 | 10.39M |
| August 27, 2026 | 10.66M |
| August 26, 2026 | 12.14M |
| August 25, 2026 | 11.77M |
| August 24, 2026 | 9.977M |
| August 21, 2026 | 7.934M |
| August 20, 2026 | 7.931M |
| August 19, 2026 | 8.314M |
| August 18, 2026 | 8.327M |
| August 17, 2026 | 8.550M |
| August 14, 2026 | 8.425M |
| August 13, 2026 | 8.314M |
| August 12, 2026 | 8.463M |
| August 11, 2026 | 8.179M |
| August 10, 2026 | 7.984M |
| August 07, 2026 | 8.058M |
| Date | Value |
|---|---|
| August 06, 2026 | 7.579M |
| August 05, 2026 | 7.442M |
| August 04, 2026 | 7.181M |
| August 03, 2026 | 7.162M |
| July 31, 2026 | 7.429M |
| July 30, 2026 | 7.609M |
| July 29, 2026 | 7.441M |
| July 28, 2026 | 7.354M |
| July 27, 2026 | 7.486M |
| July 24, 2026 | 7.573M |
| July 23, 2026 | 7.561M |
| July 22, 2026 | 7.909M |
| July 21, 2026 | 7.813M |
| July 20, 2026 | 8.016M |
| July 17, 2026 | 8.502M |
| July 16, 2026 | 8.268M |
| July 15, 2026 | 8.362M |
| July 14, 2026 | 8.728M |
| July 13, 2026 | 8.652M |
| July 10, 2026 | 8.927M |
| July 09, 2026 | 8.724M |
| July 08, 2026 | 8.895M |
| July 07, 2026 | 9.226M |
| July 06, 2026 | 8.987M |
| July 02, 2026 | 8.879M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Zymeworks, Inc. | 1.888B |
| Rhythm Pharmaceuticals, Inc. | 7.206B |
| Onconetix, Inc. | 2.870M |
| ACADIA Pharmaceuticals, Inc. | 4.790B |
| Alnylam Pharmaceuticals, Inc. | 33.26B |
Market Cap Related Metrics
| PS Ratio | 3059.70 |
| Price to Book Value | 0.2493 |
| Price | 0.7740 |
| Earnings Yield | -139.1% |